Form 4 Tracker
Easom Eric

Director, Chief Executive Officer · 2 filings · Latest: Mar 19, 2026

AN2 Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
Easom Eric — Insider Trading Activity | LevelFields AI